Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[However, recent reports of myelodysplastic syndrome/acute myeloid leukemia (t-MDS/AML) developing after treatment with immunosuppressants and G-CSF has raised concern over the use of this agent in patients with aplastic anemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• NP361786.RAu_W76cWPBI4iOHfRU_7RLHmOiwO98elIY6BC-dp0liU130_assertion description "[However, recent reports of myelodysplastic syndrome/acute myeloid leukemia (t-MDS/AML) developing after treatment with immunosuppressants and G-CSF has raised concern over the use of this agent in patients with aplastic anemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP361786.RAu_W76cWPBI4iOHfRU_7RLHmOiwO98elIY6BC-dp0liU130_provenance.
• assertion description "[However, recent reports of myelodysplastic syndrome/acute myeloid leukemia (t-MDS/AML) developing after treatment with immunosuppressants and G-CSF has raised concern over the use of this agent in patients with aplastic anemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[However, recent reports of myelodysplastic syndrome/acute myeloid leukemia (t-MDS/AML) developing after treatment with immunosuppressants and G-CSF has raised concern over the use of this agent in patients with aplastic anemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP744353.RA1sxs-CIacmduMFLGbI66X0DkFHfAHx6kEIHMt3FIKKE130_assertion description "[However, recent reports of myelodysplastic syndrome/acute myeloid leukemia (t-MDS/AML) developing after treatment with immunosuppressants and G-CSF has raised concern over the use of this agent in patients with aplastic anemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP744353.RA1sxs-CIacmduMFLGbI66X0DkFHfAHx6kEIHMt3FIKKE130_provenance.
• assertion description "[However, recent reports of myelodysplastic syndrome/acute myeloid leukemia (t-MDS/AML) developing after treatment with immunosuppressants and G-CSF has raised concern over the use of this agent in patients with aplastic anemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[However, recent reports of myelodysplastic syndrome/acute myeloid leukemia (t-MDS/AML) developing after treatment with immunosuppressants and G-CSF has raised concern over the use of this agent in patients with aplastic anemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[However, recent reports of myelodysplastic syndrome/acute myeloid leukemia (t-MDS/AML) developing after treatment with immunosuppressants and G-CSF has raised concern over the use of this agent in patients with aplastic anemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[However, recent reports of myelodysplastic syndrome/acute myeloid leukemia (t-MDS/AML) developing after treatment with immunosuppressants and G-CSF has raised concern over the use of this agent in patients with aplastic anemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[However, recent reports of myelodysplastic syndrome/acute myeloid leukemia (t-MDS/AML) developing after treatment with immunosuppressants and G-CSF has raised concern over the use of this agent in patients with aplastic anemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP331792.RAqZmqEwwbifAygmrkK1_2V-Eq5yJ0xna-LjAJHuPrFq0130_assertion description "[However, recent reports of myelodysplastic syndrome/acute myeloid leukemia (t-MDS/AML) developing after treatment with immunosuppressants and G-CSF has raised concern over the use of this agent in patients with aplastic anemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP331792.RAqZmqEwwbifAygmrkK1_2V-Eq5yJ0xna-LjAJHuPrFq0130_provenance.
• NP419924.RAjOn9-sjosLqLpJZKexDadauC20rZQ8LB5MnXLogtNEE130_assertion description "[However, recent reports of myelodysplastic syndrome/acute myeloid leukemia (t-MDS/AML) developing after treatment with immunosuppressants and G-CSF has raised concern over the use of this agent in patients with aplastic anemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP419924.RAjOn9-sjosLqLpJZKexDadauC20rZQ8LB5MnXLogtNEE130_provenance.
• NP419928.RAldcBIJwxXrxV-q2MXaAYIhb5PReCsKETDZ4CEslpatA130_assertion description "[However, recent reports of myelodysplastic syndrome/acute myeloid leukemia (t-MDS/AML) developing after treatment with immunosuppressants and G-CSF has raised concern over the use of this agent in patients with aplastic anemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP419928.RAldcBIJwxXrxV-q2MXaAYIhb5PReCsKETDZ4CEslpatA130_provenance.
• NP419931.RAir0EbSIpaAFJdAmsZyCXcfCNar_HFMp6tTeQiQwXA0M130_assertion description "[However, recent reports of myelodysplastic syndrome/acute myeloid leukemia (t-MDS/AML) developing after treatment with immunosuppressants and G-CSF has raised concern over the use of this agent in patients with aplastic anemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP419931.RAir0EbSIpaAFJdAmsZyCXcfCNar_HFMp6tTeQiQwXA0M130_provenance.
• NP419933.RAp0G3rAqrfP5rp1jI2JcRxhkIAlUu4MCVcPn4d_riFOk130_assertion description "[However, recent reports of myelodysplastic syndrome/acute myeloid leukemia (t-MDS/AML) developing after treatment with immunosuppressants and G-CSF has raised concern over the use of this agent in patients with aplastic anemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP419933.RAp0G3rAqrfP5rp1jI2JcRxhkIAlUu4MCVcPn4d_riFOk130_provenance.
• NP419935.RAu_fPweFgrmOq-LLKry2KyukgOvzZOfmR6a4oMqzzY6E130_assertion description "[However, recent reports of myelodysplastic syndrome/acute myeloid leukemia (t-MDS/AML) developing after treatment with immunosuppressants and G-CSF has raised concern over the use of this agent in patients with aplastic anemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP419935.RAu_fPweFgrmOq-LLKry2KyukgOvzZOfmR6a4oMqzzY6E130_provenance.
• NP419938.RAsYrjRvg9nW_7A-xDopJkUJt8wJNyRaywE_4qa6eW_DU130_assertion description "[However, recent reports of myelodysplastic syndrome/acute myeloid leukemia (t-MDS/AML) developing after treatment with immunosuppressants and G-CSF has raised concern over the use of this agent in patients with aplastic anemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP419938.RAsYrjRvg9nW_7A-xDopJkUJt8wJNyRaywE_4qa6eW_DU130_provenance.
• NP331840.RA0NZxZFLEvhtskFFN0WVTzUAufWZvQL0KDVunrBJLw7c130_assertion description "[However, recent reports of myelodysplastic syndrome/acute myeloid leukemia (t-MDS/AML) developing after treatment with immunosuppressants and G-CSF has raised concern over the use of this agent in patients with aplastic anemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP331840.RA0NZxZFLEvhtskFFN0WVTzUAufWZvQL0KDVunrBJLw7c130_provenance.
• NP332084.RAPxfFGkpdtahmsg2Gjg3LTbtenm70NNwyFj__d4mNoBs130_assertion description "[However, recent reports of myelodysplastic syndrome/acute myeloid leukemia (t-MDS/AML) developing after treatment with immunosuppressants and G-CSF has raised concern over the use of this agent in patients with aplastic anemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP332084.RAPxfFGkpdtahmsg2Gjg3LTbtenm70NNwyFj__d4mNoBs130_provenance.
• NP419934.RAJgczAPwneIrdM-UlMbh0g7w94dZC2n42VKzsE4wSIsI130_assertion description "[However, recent reports of myelodysplastic syndrome/acute myeloid leukemia (t-MDS/AML) developing after treatment with immunosuppressants and G-CSF has raised concern over the use of this agent in patients with aplastic anemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP419934.RAJgczAPwneIrdM-UlMbh0g7w94dZC2n42VKzsE4wSIsI130_provenance.